Efficacy and security of intermittent repeated levosimendan administration in patients with advanced heart failure: a randomized, double-blind, placebo controlled multicenter trial: LAICA study.
Event:
HEART FAILURE 2016
Topic:
Acute Heart Failure
Session:
Late Breaking Trials I: Focus on acute heart failure